GoodRx Releases First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Nasdaq futures fall after record Samsung profit fails to calm AI chip worries
- Oil gains after vessels attacked near Strait of Hormuz
- Citi says SpaceX stock has path to $900+ valuation. Here’s how
- Tesla stock target lifted at RBC on potential SpaceX merger
- Short squeezes more likely than widespread selling: Citi
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
GoodRx Holdings, Inc. (GDRX) Reports In-Line Q1 EPS, Offers Guidance
May 13, 2021 4:22 PM EDTGoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $160.4 million versus the consensus estimate of $160.58 million.
GUIDANCE:
GoodRx Holdings, Inc. sees Q2 2021 revenue of $172-176 million, versus... More
